Delivery Order SPE2DB22D1017-SPE2DB24FF7MN
Award Date
5/9/24
Potential Completion Date
5/10/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $3,494.92, has a completion date of February 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,654.94 delivery order contract is for the supply of GARDASIL 9 vaccine syringes. The contract has an ultimate completion date of December 27, 2024 and is a firm fixed-price agreement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $7,115.34, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product, with a completion date of June 6, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award, valued at $13,446.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GARDASIL 9 syringes, a vaccine product, and is a firm fixed-price delivery order with an ultimate completion date of August 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $7,928.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GARDASIL 9 SYRINGE 0.5ML. The contract is a Firm Fixed Price Delivery Order with a completion date of May 18, 2022. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide GARDASIL 9 (0.5mL syringe) vaccines. The delivery order, valued at $7,842.50, has a firm fixed price and an ultimate completion date of May 17, 2024. It is not a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Amerisourcebergen Corporation. The $10,579.40 firm fixed-price delivery order is for the supply of GARDASIL 9 syringes, a vaccine product, with an ultimate completion date of May 2, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded a $8,720.22 firm-fixed price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of GARDASIL 9 SYRINGE 0.5ML vaccines. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,889.10 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of GARDASIL 9 syringes (0.5 mL) to the U.S. government. The $9,700.74 firm fixed-price contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) and has an ultimate completion date of April 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...